FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133958055> ?p ?o ?g. }

• W2133958055 endingPage "116" @default.
• W2133958055 startingPage "105" @default.
• W2133958055 abstract "Anaplastic thyroid carcinoma (ATC) is considered one of the most aggressive malignancies, having a poor prognosis and being refractory to conventional chemotherapy and radiotherapy. Alteration in histone deacetylase (HDAC) activity has been reported in cancer, thus encouraging the development of HDAC inhibitors, whose antitumor action has been shown in both solid and hematological malignancies. However, the molecular basis for their tumor selectivity is unknown. To find an innovative therapy for the treatment of ATCs, we studied the effects of deacetylase inhibitors on thyroid tumorigenesis models. We show that HDACs 1 and 2 are overexpressed in ATCs compared with normal cells or benign tumors and that HDAC inhibitors induce apoptosis selectively in the fully transformed thyroid cells. Our results indicate that these phenomena are mediated by a novel action of HDAC inhibitors that reduces tumor necrosis factor-related apoptosis-inducing ligand protein degradation by affecting the ubiquitin-dependent pathway. Indeed, the combined treatment with HDAC and proteasome inhibitors results in synergistic apoptosis. These results strongly encourage the preclinical application of the combination deacetylase-proteasome inhibitors for the treatment of ATC." @default.
• W2133958055 created "2016-06-24" @default.
• W2133958055 creator A5007157411 @default.
• W2133958055 creator A5012839091 @default.
• W2133958055 creator A5023140151 @default.
• W2133958055 creator A5039682482 @default.
• W2133958055 creator A5050600005 @default.
• W2133958055 creator A5055517422 @default.
• W2133958055 creator A5080238293 @default.
• W2133958055 creator A5085357602 @default.
• W2133958055 date "2009-10-05" @default.
• W2133958055 modified "2023-10-17" @default.
• W2133958055 title "Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation" @default.
• W2133958055 cites W1551972473 @default.
• W2133958055 cites W1976298557 @default.
• W2133958055 cites W1983315005 @default.
• W2133958055 cites W1985944726 @default.
• W2133958055 cites W1987506447 @default.
• W2133958055 cites W1996153208 @default.
• W2133958055 cites W2004980848 @default.
• W2133958055 cites W2009204250 @default.
• W2133958055 cites W2010140285 @default.
• W2133958055 cites W2019276845 @default.
• W2133958055 cites W2022285476 @default.
• W2133958055 cites W2023690110 @default.
• W2133958055 cites W2031954417 @default.
• W2133958055 cites W2038118195 @default.
• W2133958055 cites W2045255643 @default.
• W2133958055 cites W2052453190 @default.
• W2133958055 cites W2053167405 @default.
• W2133958055 cites W2058232002 @default.
• W2133958055 cites W2063819389 @default.
• W2133958055 cites W2066264051 @default.
• W2133958055 cites W2067057763 @default.
• W2133958055 cites W2070433411 @default.
• W2133958055 cites W2080866562 @default.
• W2133958055 cites W2086384126 @default.
• W2133958055 cites W2090062530 @default.
• W2133958055 cites W2093419517 @default.
• W2133958055 cites W2094194610 @default.
• W2133958055 cites W2098536205 @default.
• W2133958055 cites W2099803844 @default.
• W2133958055 cites W2104875539 @default.
• W2133958055 cites W2121302081 @default.
• W2133958055 cites W2135619784 @default.
• W2133958055 cites W2139476591 @default.
• W2133958055 cites W2139977915 @default.
• W2133958055 cites W2140113033 @default.
• W2133958055 cites W2143658931 @default.
• W2133958055 cites W2143894420 @default.
• W2133958055 cites W2149379768 @default.
• W2133958055 cites W2154993209 @default.
• W2133958055 cites W2157433715 @default.
• W2133958055 cites W2157510736 @default.
• W2133958055 cites W2167237706 @default.
• W2133958055 cites W2168193856 @default.
• W2133958055 cites W2168261275 @default.
• W2133958055 cites W2168455351 @default.
• W2133958055 cites W2170175754 @default.
• W2133958055 cites W2170925020 @default.
• W2133958055 cites W4248975159 @default.
• W2133958055 doi "https://doi.org/10.1038/onc.2009.306" @default.
• W2133958055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19802013" @default.
• W2133958055 hasPublicationYear "2009" @default.
• W2133958055 type Work @default.
• W2133958055 sameAs 2133958055 @default.
• W2133958055 citedByCount "58" @default.
• W2133958055 countsByYear W21339580552012 @default.
• W2133958055 countsByYear W21339580552013 @default.
• W2133958055 countsByYear W21339580552014 @default.
• W2133958055 countsByYear W21339580552015 @default.
• W2133958055 countsByYear W21339580552016 @default.
• W2133958055 countsByYear W21339580552017 @default.
• W2133958055 countsByYear W21339580552018 @default.
• W2133958055 countsByYear W21339580552019 @default.
• W2133958055 countsByYear W21339580552020 @default.
• W2133958055 countsByYear W21339580552022 @default.
• W2133958055 countsByYear W21339580552023 @default.
• W2133958055 crossrefType "journal-article" @default.
• W2133958055 hasAuthorship W2133958055A5007157411 @default.
• W2133958055 hasAuthorship W2133958055A5012839091 @default.
• W2133958055 hasAuthorship W2133958055A5023140151 @default.
• W2133958055 hasAuthorship W2133958055A5039682482 @default.
• W2133958055 hasAuthorship W2133958055A5050600005 @default.
• W2133958055 hasAuthorship W2133958055A5055517422 @default.
• W2133958055 hasAuthorship W2133958055A5080238293 @default.
• W2133958055 hasAuthorship W2133958055A5085357602 @default.
• W2133958055 hasBestOaLocation W21339580551 @default.
• W2133958055 hasConcept C104317684 @default.
• W2133958055 hasConcept C119157956 @default.
• W2133958055 hasConcept C121608353 @default.
• W2133958055 hasConcept C134018914 @default.
• W2133958055 hasConcept C190283241 @default.
• W2133958055 hasConcept C27740335 @default.
• W2133958055 hasConcept C2776202225 @default.
• W2133958055 hasConcept C2776262904 @default.
• W2133958055 hasConcept C2778305200 @default.
• W2133958055 hasConcept C2779761222 @default.

• next